[Fully implantable catheter systems. Long-term results--complications].
Between January 1984 and March 1989 we employed two different types of totally implantable venous access systems (57 Port A Cath/25 Theraport) in 82 patients (24 male/58 female). The indication for implantation was the need for long-term parenteral drug treatment of a malignant disease. The duration of the follow-up period was limited by the residual lifespan of the respective patient, 7.2 months on average (range: 3-37 months). In more than 90% (n = 75; 91.5%) of the patients the device functioned normally. Complications were observed in 7 patients (8.5%) (thrombosis in 3, pneumothorax in 2, infections in 2). The results indicate that the use of a totally implantable venous access system is a useful supportive measure in patients requiring long-term Cytostatic and parenteral therapy.
Wenke
K
K
Herzchirurgische Klinik, Universität München.
Markewitz
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002405:Catheterization, Central Venous / Q000295:instrumentation*; D002406:Catheterization, Peripheral / Q000295:instrumentation*; D002408:Catheters, Indwelling / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy; D010289:Parenteral Nutrition, Total
D000970:Antineoplastic Agents
Vollständig implantierbare Kathetersysteme. Langzeitergebnisse--Komplikationen.